Sinopharm Group Co. Ltd

Research Sinopharm Group Co. Ltd (X2S) on Bullrun: market cap EUR 5.53B, P/E 6.1, dividend yield 4.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerX2S
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryMedical Distribution
• CurrencyEUR
• Market capEUR 5.53B
• P/E6.1
• Dividend yield4.8%
• Financial periodFY2025
• RevenueEUR 575.17B
• Revenue growth-1.6%
• Net incomeEUR 7.16B
• Free cash flowEUR 12.52B
• Gross margin7.2%

Valuation Snapshot

latest market cap is EUR 5.53B; P/E is 6.1; dividend yield is 4.8%.

About Sinopharm Group Co. Ltd

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.

Frequently asked questions

What is Sinopharm Group Co. Ltd's market cap?

Sinopharm Group Co. Ltd's market capitalization is EUR 5.53B.

What is Sinopharm Group Co. Ltd's P/E ratio?

Sinopharm Group Co. Ltd's price-to-earnings (P/E) ratio is 6.1.

Does Sinopharm Group Co. Ltd pay a dividend?

Sinopharm Group Co. Ltd has a dividend yield of 4.8%.

What does Sinopharm Group Co. Ltd do?

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China.